BeyondSpring Announces Late-Breaking Oral Presentation of Final Phase 3 DUBLIN-3 Data with the Plinabulin/Docetaxel Combination Versus Docetaxel Alone in 2nd/3rd Line Non-Small Cell Lung Cancer Patients with EGFR Wild Type at the European Society for Medical Oncology 2021 Congress

NEXT STORY
Michael Didocha Joins Telix as Chief Financial Officer, Americas
PREV STORY
Outlook on the DNA Vaccines Global Market to 2026 – Featuring Astellas Pharma, AstraZeneca and Pfizer Among Others
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Integra LifeSciences Launches Integra® Titan™ Reverse Shoulder System-S

PLAINSBORO, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading ...

author_avatar
NASDAQ Market News

Curis Announces CA-170 Poster Presentation at ESMO 2017 Congress

LEXINGTON, Mass., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

author_avatar
NASDAQ Market News

Immunocore Announces that U.S. Food and Drug Administration and European Medicines Agency accept Biologics License Application and Marketing Authorization Application for Tebentafusp in Metastatic Uveal Melanoma

author_avatar
NASDAQ Market News